Depth Of Response To Daratumumab (Dara), Lenalidomide, Bortezomib, And Dexamethasone (Rvd) Improves Over Time In Patients (Pts) With Transplant-Eligible Newly Diagnosed Multiple Myeloma (Ndmm): Griffin Study Update

BLOOD(2019)

引用 52|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要